Multimodal Fetal and Placental Imaging and Biomarkers of Clinical Outcomes in Opioid Use Disorder
Key facts
- Who runs it
- Senthil Sadhasivam
- Where
- Indianapolis and Pittsburgh, United StatesSee the 2 sites
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 250 people, planned
- Started
- 13 Feb 2024
- Expected to end
- 1 Dec 2029
- Type of study
- Observational, 2 groups
- Treatments tested
- Buprenorphine or Methadone Treatment
- Fetal and Placental MRI
- Child Developmental Assessment
- Questionnaires
- Blood and Placental Samples
- Record updated
- 14 July 2026
Who can take part
- Age
- 18 years to 100 years
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Age >18 years
- Currently taking buprenorphine or methadone for OUD and are enrolled in a prenatal opioid maintenance program
- Singleton Pregnancy
- Planned delivery at Indiana University or University of Pittsburgh study sites
Who cannot take part
- Serious maternal medical illness as deemed by study physician investigators that would make it challenging to comply with study procedures
- HIV or AIDS; Infants with prenatal opioid exposure:; Inclusion:
- Born to mother enrolled in Opioid Use Disorder arm of study; Exclusion:; Major congenital anomalies or genetic syndromes affecting neurodevelopment; Control Pregnant Women:; Inclusion:
- Serious maternal medical illness as deemed by study physician investigators that would make it challenging to comply with study procedures
- HIV or AIDS
- Any history of opioid misuse before or during pregnancy-per self-report and clinical notes; Control infants:; Inclusion:; Born to control pregnant mother enrolled in study; Exclusion:; Any major congenital anomalies, genetic abnormalities, neurologic abnormalities, syndromes, or chronic medical conditions affecting neurodevelopment
- Women >18 Years of age
- Known or suspected major fetal/ neonatal congenital abnormalities
- Prenatal buprenorphine or methadone exposure
- Healthy singleton pregnancy
- Planned delivery at Indiana University or University of Pittsburgh study sites; Exclusion:
- Known or suspected major fetal congenital abnormalities
Other criteria
- Pregnant women with opioid use disorder
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Where in United States
- Riley Hospital for ChildrenIndianapolis, United StatesEnrolling by invitation
- University of PittsburghPittsburgh, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The goal of this observational study is to learn about the long term effects of prenatal opioid exposure. The main objectives are:
Read full original descriptionShow less
* Long term goal: to improve the safety and efficacy of maternal Opioid Use Disorder (OUD) and eliminate neonatal opioid withdrawal syndrome (NOWS) and poor childhood neurodevelopment. * To characterize prenatal opioid exposure (POE) related placental and fetal brain structural and functional disruptions using longitudinal placenta-fetal brain magnetic resonance imaging (MRI) and determine proteomic, genomic, and epigenetic signatures of NOWS and poor infant neurodevelopment.
In this study participants will:
* Receive two placental-fetal MRIs, one during second trimester and one in third trimester. * Answer surveys relating to their medical and social history. * Have blood drawn during pregnancy and delivery. * Child development follow up: answer surveys on their child's development milestones and at one year of life they will undergo a development assessment.
The 2 groups in the trial
- Pregnant Mothers with Opioid Use Disorder
150 pregnant mothers with opioid use disorder who are on buprenorphine or methadone treatment
Treatment: Buprenorphine or Methadone Treatment, Fetal and Placental MRI, Child Developmental Assessment, Questionnaires, and Blood and Placental Samples
- Pregnant Mothers
100 pregnant mother who to not have a history of opioid use disorder
Treatment: Fetal and Placental MRI, Child Developmental Assessment, Questionnaires, and Blood and Placental Samples
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT06415994, who can take part
- Record updated
- 14 July 2026